Literature DB >> 28283378

The effects of synthetic cannabinoid UR-144 on the human body-A review of 39 cases.

Piotr Adamowicz1, Joanna Gieroń2, Dominika Gil2, Wojciech Lechowicz2, Agnieszka Skulska2, Bogdan Tokarczyk2.   

Abstract

UR-144 [(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone] is a synthetic cannabinoid, which has been detected in many 'legal highs', seized from the global drug market since the beginning of 2012. It has gained popularity as a 'legal' alternative to classic cannabis in countries where it was not controlled. Despite the widespread distribution of this substance, the data on its effects on the human body are scarce. Therefore, this paper describes the results of analysis and observed effects in 39 cases in which UR-144 was determined in blood. Symptoms were noted from the blood sampling forms filled out by the representative doctor. The determined concentrations of UR-144 were in the range of trace amounts (LOD-0.15ng/mL; LOQ-0.5ng/mL) up to 17ng/mL. The most common observed effects included slurred speech, dilated pupils, sluggish and abnormal pupillary reaction, cheerful behaviour, poor coordination, and staggering. Less frequently observed were: verbosity, narrow pupils, loss of consciousness, pale or reddened facial skin, blackout, euphoria, agitation, hallucinations, hindered communication, shaking hands, seizures, convulsions, somnolence, delayed movements, redness of the conjunctiva, and tachycardia. The discussed cases show the effects observed after UR-144 use. This study can assist in the recognition of possible effects caused by this substance.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood concentrations; Effects; Symptoms; Synthetic cannabinoid; UR-144

Mesh:

Substances:

Year:  2017        PMID: 28283378     DOI: 10.1016/j.forsciint.2017.02.031

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  7 in total

Review 1.  Interpol review of toxicology 2016-2019.

Authors:  Wing-Sum Chan; George Fai Wong; Chi-Wai Hung; Yau-Nga Wong; Kit-Mai Fung; Wai-Kit Lee; Kwok-Leung Dao; Chung-Wing Leung; Kam-Moon Lo; Wing-Man Lee; Bobbie Kwok-Keung Cheung
Journal:  Forensic Sci Int       Date:  2020-05-23       Impact factor: 2.395

Review 2.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

3.  Determination of the Synthetic Cannabinoids JWH-122, JWH-210, UR-144 in Oral Fluid of Consumers by GC-MS and Quantification of Parent Compounds and Metabolites by UHPLC-MS/MS.

Authors:  Nunzia La Maida; Manuela Pellegrini; Esther Papaseit; Clara Pérez-Mañá; Lourdes Poyatos; Mireia Ventura; Liliana Galindo; Francesco Paolo Busardò; Simona Pichini; Magí Farré; Emilia Marchei
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

4.  Adulteration of low-delta-9-tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services.

Authors:  Manuela Carla Monti; Jill Zeugin; Konrad Koch; Natasa Milenkovic; Eva Scheurer; Katja Mercer-Chalmers-Bender
Journal:  Drug Test Anal       Date:  2022-02-02       Impact factor: 3.234

Review 5.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

6.  Simple screening procedure for 72 synthetic cannabinoids in whole blood by liquid chromatography-tandem mass spectrometry.

Authors:  Katarzyna Ambroziak; Piotr Adamowicz
Journal:  Forensic Toxicol       Date:  2018-01-31       Impact factor: 4.096

7.  Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users.

Authors:  Nunzia La Maida; Esther Papaseit; Lucia Martínez; Clara Pérez-Mañá; Lourdes Poyatos; Manuela Pellegrini; Simona Pichini; Roberta Pacifici; Mireia Ventura; Liliana Galindo; Francesco Paolo Busardò; Magí Farré
Journal:  Biology (Basel)       Date:  2021-03-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.